News & Updates
Filter by Specialty:
Anaphylaxis after COVID mRNA vaccination relatively rare
Anaphylactic reactions warranting treatment after receipt of COVID-19 mRNA vaccinations appear to be relatively rare, according to a US study presented at AAAAI 2022.
Anaphylaxis after COVID mRNA vaccination relatively rare
06 Apr 2022Olfactory, gustatory disorders persist after COVID-19
Olfactory and gustatory dysfunctions, even when assessed through validated psychophysical tests, are common chronic symptoms after the coronavirus disease 2019 (COVID-19), a recent study has found.
Olfactory, gustatory disorders persist after COVID-19
03 Apr 2022What makes kids more susceptible to community-acquired severe pneumonia?
Community-acquired severe pneumonia is more likely to develop in young boys and children with severe stunting, reports a recent study. Fever, illness duration, and a history of prior medical care are also important predictive factors for severe pneumonia.
What makes kids more susceptible to community-acquired severe pneumonia?
30 Mar 2022Knowledge of HCV high among those successfully treated with DAAs
Patients successfully treated with direct-acting antivirals (DAAs) show high knowledge about hepatitis C virus (HCV) infection, a recent study has shown.
Knowledge of HCV high among those successfully treated with DAAs
30 Mar 2022Methenamine hippurate prevents recurrent UTI in women
Nonantibiotic treatment with methenamine hippurate shows high levels of efficacy in women with a history of recurrent episodes of urinary tract infection (UTI), which is comparable to the current guideline-recommended prophylaxes (ie, long-course, low-dose antibiotics), according to a study.